本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Atara Biotherapeutics

8.50
+0.03000.35%
成交量:7,843.00
成交额:6.57万
市值:5,772.86万
市盈率:-0.74
高:8.68
开:8.30
低:8.21
收:8.47
数据加载中...
2024/12/23

重要事件披露

Form 8-K - Current report
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/10/15

重要事件披露

Form 8-K - Current report
2024/09/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/05

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report